...
首页> 外文期刊>Journal of viral hepatitis. >Access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study: a person-centred approach
【24h】

Access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study: a person-centred approach

机译:瑞士丙型肝炎队列研究中获得治疗和治疗结局的途径:以人为本的方法

获取原文
获取原文并翻译 | 示例
           

摘要

Socio-demographic and behavioural characteristics are associated with delayed diagnosis and disease progression in HCV-infected persons. However, many analyses focused on single variables rather than groups defined by several variables. We used latent class analysis to study all 4488 persons enrolled in the Swiss Hepatitis C Cohort Study. Groups were identified using predefined variables at enrolment. The number of groups was selected using the Bayesian information criterion. Mortality, loss to follow-up, cirrhosis, treatment status and response to antivirals were analysed using Laplace and logistic regressions. We identified five groups and named them according to their characteristics: persons who inject drugs, male drinkers, Swiss employees, foreign employees and retirees. Two groups did not conform to common assumptions about persons with chronic hepatitis C and were already in an advanced stage of the disease at enrolment: male drinkers' and retirees' had a high proportion of cirrhosis at enrolment (15% and 16% vs <10.3%), and the shortest time to death (adjusted median time 8.7 years and 8.8 years vs >9.0). Male drinkers' also had high substance use, but they were well educated and were likely to be employed. This analysis may help identifying high-risk groups which may benefit from targeted interventions.
机译:社会人口统计学和行为特征与HCV感染者的延迟诊断和疾病进展有关。但是,许多分析只关注单个变量,而不是几个变量定义的组。我们使用潜在类别分析来研究所有参与瑞士丙型肝炎队列研究的4488人。在注册时使用预定义的变量来识别组。使用贝叶斯信息准则选择组数。使用Laplace和Logistic回归分析死亡率,失访率,肝硬化,治疗状况和对抗病毒药的反应。我们确定了五个群体,并根据其特征命名:注射毒品的人,男性饮酒者,瑞士雇员,外国雇员和退休人员。两组不符合关于慢性丙型肝炎患者的共同假设,并且在入组时已处于疾病晚期:男性饮酒者和退休者入选时肝硬化的比例较高(15%和16%比<10.3 %)和最短的死亡时间(调整后的中位数时间分别为8.7年和8.8年和> 9.0)。男性饮酒者也使用大量毒品,但他们受过良好的教育,很可能会被雇用。这项分析可能有助于确定可从目标干预措施中受益的高风险人群。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号